54
Views
2
CrossRef citations to date
0
Altmetric
Patent Evaluations

Novel therapeutics based on tau/microtubule dynamics: WO2008084483

, PhD & , MS
Pages 1335-1338 | Published online: 15 Apr 2009

Bibliography

  • Grundke-Iqbal I, Iqbal K, Quinlan M, et al. Microtubule-associated protein tau. A component of Alzheimer paired helical filaments. J Biol Chem 1986;261(13):6084-9
  • Cash AD, Aliev G, Siedlak SL, et al. Raina, Harry V. Vinters, Massimo Tabaton, Anne B. Johnson, Manuel Paula-Barbosa, Jesus Avíla, Paul K. Jones, Rudy J. Castellani, Mark A. Smith and George Perry, microtubule reduction in Alzheimer's disease and aging is independent of filament formation. Am J Pathol 2003;162:1623-7
  • Anderton BH, Callahan L, Coleman P, et al. Thomas ohm and charles weaver dendritic changes in Alzheimer's disease and factors that may underlie these changes. Prog Neurobiol 1998;55(6):595-609
  • Scheff SW, Price DA, Schmitt FA, et al. Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment. Neurology 2007;68:1501-8
  • Jack CR Jr, Lowe VJ, Senjem ML, et al. 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment. Brain 2008;55:1-16
  • Alonso A del C, Grundke lqbal I, Iqbal K. Hyperphosphorylated tau from Alzheimer disease brain disassembles microtubules and sequesters normal tau into tangles filaments. Nature Med 1996;2:783-7
  • Alonso A del C, Zaidi T, Novak M, et al. Hyperphosphorylation induces self – assembly of tau into tangles of paired helical filaments/straight filaments. Proc Natl Acad Sci USA 2001;98:6923-8
  • Patočka J, Slaninová J, Kunešová G. Neuroprotective peptides as drug candidates against Alzheimer's diasease. J Appl Biomed 2005;3:67-73
  • Krejčová G, Patočka J, Slaninová J. Effect of humanin analogues on experimentally induced impairment of spatial memory in rats. J Pept Sci 2004;10:636-9
  • Mamiya T, Ukai M. [Gly(14)]-Humanin improved the learning and memory impairment induced by scopolamine in vivo. Br J Pharmacol 2001;134:1597-9
  • Gozes I, Divinski I. NAP, a neuroprotective drug candidate in clinical trials, stimulates microtubule assembly in the living cell. Curr Alzheimer Res 2007;4(5):507-9
  • Bhattacharya R, Cabral F. A ubiquitous beta-tubulin disrupts microtubule assembly and inhibits cell proliferation. Mol Biol Cell 2004;15(7):3123-31
  • Argaraña CE, Arce CA, Barra HS, Caputto R. In vivo incorporation of [14C]tyrosine into the C-terminal position of the alpha subunit of tubulin. Arch Biochem Biophys 1977;180(2):264-8
  • Jehle T, Dimitriu C, Auer S, et al. The neuropeptide NAP provides neuroprotection against retinal ganglion cell damage after retinal ischemia and optic nerve crush. Graefes Arch Clin Exp Ophthalmol 2008;246(9):1255-63. Erratum in: Graefes Arch Clin Exp Ophthalmol 2008;246(9):1355. [Epub 15 Apr 2008]
  • Matsuoka Y, Jouroukhin Y, Gray AJ, et al. A neuronal microtubule-interacting agent, NAPVSIPQ, reduces tau pathology and enhances cognitive function in a mouse model of Alzheimer's disease. J Pharmacol Exp Ther 2008;325(1):146-53
  • Vulih-Shultzman I, Pinhasov A, Mandel S, et al. Activity-dependent neuroprotective protein snippet NAP reduces tau hyperphosphorylation and enhances learning in a novel transgenic mouse model. J Pharmacol Exp Ther 2007;323(2):438-49
  • Matsuoka Y, Gray AJ, Hirata-Fukae C, et al. Intranasal NAP administration reduces accumulation of amyloid peptide and tau hyperphosphorylation in a transgenic mouse model of Alzheimer's disease at early pathological stage. J Mol Neurosci 2007;31(2):165-70
  • Laurén J, Gimbel DA, Nygaard HB, et al. Cellular prion protein mediates impairment of synaptic plasticity by amyloid-oligomers. Nature 2009;457:1128-32

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.